Literature DB >> 29332573

Torsades de Pointes in Patients with Polymyalgia Rheumatica.

Pietro Enea Lazzerini1, Iacopo Bertolozzi2, Maurizio Acampa3, Rosella Fulceri4, Franco Laghi-Pasini1, Pier Leopoldo Capecchi1.   

Abstract

Polymyalgia rheumatica (PMR) represents the most common inflammatory rheumatic disease of the elderly. It is characterized by synovitis of proximal joints and extra-articular synovial structures, along with chronic high-grade systemic inflammation. PMR is closely related to giant cell arteritis (GCA), a large-vessel vasculitis that involves the major branches of the aorta, particularly the extracranial branches of carotid artery including temporal arteries. It is currently believed that PMR and GCA may represent different manifestations of the same disease process. Chronic systemic inflammation is presently recognized as one of the key pathogenic mechanisms underlying cardiovascular disease and associated complications, including cardiac arrhythmias and sudden death. In this regard, several studies demonstrated that besides promoting structural heart disease, inflammatory activation may also be per se arrhythmogenic, via cytokine-mediated effects on cardiac electrophysiology. In particular, increasing evidence points to inflammation as a novel risk factor for QTc prolongation and related life-threatening arrhythmias, specifically Torsade de Pointes (TdP). Starting from the report of two cases of TdP occurring in PMR patients with active disease and elevated circulating IL-6 levels, we here reviewed literature data regarding heart involvement and arrhythmic events in PMR/GCA, as well as TdP risk in inflammatory diseases. Potential underlying mechanisms were dissected, by focusing on the driving role of inflammatory activation. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Torsades de Pointes; arrhythmias; cardiovascular disease; coronary artery disease; giant cell arteritis; interleukin-6; polymyalgia rheumatica; sudden death; systemic inflammation.

Mesh:

Year:  2018        PMID: 29332573     DOI: 10.2174/1381612824666180111111124

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

Review 1.  Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases.

Authors:  Sophie I Mavrogeni; Petros P Sfikakis; Theodoros Dimitroulas; Loukia Koutsogeorgopoulou; George Markousis-Mavrogenis; George Poulos; Genovefa Kolovou; George Theodorakis; George D Kitas
Journal:  Rheumatol Int       Date:  2018-07-24       Impact factor: 2.631

Review 2.  Ventricular Arrhythmias in First Acute Myocardial Infarction: Epidemiology, Mechanisms, and Interventions in Large Animal Models.

Authors:  Stefan Michael Sattler; Lasse Skibsbye; Dominik Linz; Anniek Frederike Lubberding; Jacob Tfelt-Hansen; Thomas Jespersen
Journal:  Front Cardiovasc Med       Date:  2019-11-05

3.  Premature atrial contractions with multiple patterns of aberrant conduction followed by torsade de pointes in a patient with polymyalgia rheumatica: A case report.

Authors:  Koji Takahashi; Mina Yamashita; Tomoki Sakaue; Daijiro Enomoto; Shigeki Uemura; Takafumi Okura; Shuntaro Ikeda; Masafumi Takemoto; Yutaka Utsunomiya; Takashi Hyodo; Masayuki Ochi; Satoshi Higuchi
Journal:  Medicine (Baltimore)       Date:  2021-09-17       Impact factor: 1.889

4.  Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction.

Authors:  George Markousis-Mavrogenis; George Poulos; Theodoros Dimitroulas; Aikaterini Giannakopoulou; Clio Mavragani; Vasiliki Vartela; Dionysia Manolopoulou; Genovefa Kolovou; Paraskevi Voulgari; Petros P Sfikakis; George D Kitas; Sophie I Mavrogeni
Journal:  Diagnostics (Basel)       Date:  2021-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.